Business ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Approval Phase 2 Trials Product Development Research and Development Partnerships Outsourcing ARTEMIS Phase 3 Trial Duchenne Muscular Dystrophy Oncology Drug Efficacy Drug Approval Process Phase 3 Studies Patient Cohorts Autoimmune Diseases Drug Trials Diabetes Research Phase 1 Studies

Eli Lilly Prepares €15 Billion Abivax Offer, Eyes Next Wave of Weight-Loss Drugs

The company awaits French Finance Ministry guidance on foreign investment rules before making a formal approach.

AnaptysBio CMO Trims Stake After Option Exercise as Director Reports Separate Sale

MPM BioImpact Exits MBX, MoonLake, Crinetics in Q3, SEC Filing Shows

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Arcutis Turns First Profit on Zoryve Surge, Lifts Outlook as Stock Jumps

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

Takeda Strikes $11 Billion-Plus Oncology Deal With Innovent, Pays $1.2 Billion Upfront

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

S&P 500 Gains 1% on Tesla Robotaxi Debut and Merger Speculation; Supermicro Shares Plunge